Therapie der pulmonal arteriellen Hypertonie

H Klose; L Harbaum; T Oqueka; M Simon; E Grünig

doi:10.1055/s-0034-1392103

Therapie der pulmonal arteriellen Hypertonie

Standard

Therapie der pulmonal arteriellen Hypertonie. / Klose, H ; Harbaum, L ; Oqueka, T; Simon, M; Grünig, E.

In: PNEUMOLOGIE, Vol. 69, No. 8, 08.2015, p. 483-93; quiz 494-5.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

Harvard

Klose, H , Harbaum, L , Oqueka, T, Simon, M & Grünig, E 2015, 'Therapie der pulmonal arteriellen Hypertonie', PNEUMOLOGIE, vol. 69, no. 8, pp. 483-93; quiz 494-5. https://doi.org/10.1055/s-0034-1392103

APA

Klose, H., Harbaum, L., Oqueka, T., Simon, M., & Grünig, E. (2015). Therapie der pulmonal arteriellen Hypertonie. PNEUMOLOGIE, 69(8), 483-93; quiz 494-5. https://doi.org/10.1055/s-0034-1392103

Vancouver

Klose H , Harbaum L , Oqueka T, Simon M, Grünig E. Therapie der pulmonal arteriellen Hypertonie. PNEUMOLOGIE. 2015 Aug;69(8):483-93; quiz 494-5. https://doi.org/10.1055/s-0034-1392103

Bibtex

@article{cb140c4b5cdf4a718c269e4318e90624,

title = "Therapie der pulmonal arteriellen Hypertonie",

abstract = "Pulmonary hypertension (PH) is classified into five distinct groups according to the fifth world conference in Nice 2013. Pulmonary arterial hypertension (PAH) comprises idiopathic PAH, hereditary PAH, drug-induced and associated PAH. Right heart catheterization is essential for the diagnosis of PH and should precede initiation of a targeted PAH therapy. Besides general measures and supportive therapy, four different classes of targeted drugs have been approved for the treatment of PAH. Combination therapy, either sequential or initial (up-front), is increasingly gaining recognition. Risk stratification and treatment goals have been defined to guide therapeutic decisions. However, cure is still far from reach and lung transplantation is an important treatment option for patients with end-stage disease under optimal supportive and targeted drug therapy.",

author = "H Klose and L Harbaum and T Oqueka and M Simon and E Gr{\"u}nig",

note = "{\textcopyright} Georg Thieme Verlag KG Stuttgart · New York.",

year = "2015",

month = aug,

doi = "10.1055/s-0034-1392103",

language = "Deutsch",

volume = "69",

pages = "483--93; quiz 494--5",

journal = "PNEUMOLOGIE",

issn = "0934-8387",

publisher = "Georg Thieme Verlag KG",

number = "8",

}

RIS

TY - JOUR

T1 - Therapie der pulmonal arteriellen Hypertonie

AU - Klose, H

AU - Harbaum, L

AU - Oqueka, T

AU - Simon, M

AU - Grünig, E

PY - 2015/8

Y1 - 2015/8

N2 - Pulmonary hypertension (PH) is classified into five distinct groups according to the fifth world conference in Nice 2013. Pulmonary arterial hypertension (PAH) comprises idiopathic PAH, hereditary PAH, drug-induced and associated PAH. Right heart catheterization is essential for the diagnosis of PH and should precede initiation of a targeted PAH therapy. Besides general measures and supportive therapy, four different classes of targeted drugs have been approved for the treatment of PAH. Combination therapy, either sequential or initial (up-front), is increasingly gaining recognition. Risk stratification and treatment goals have been defined to guide therapeutic decisions. However, cure is still far from reach and lung transplantation is an important treatment option for patients with end-stage disease under optimal supportive and targeted drug therapy.

AB - Pulmonary hypertension (PH) is classified into five distinct groups according to the fifth world conference in Nice 2013. Pulmonary arterial hypertension (PAH) comprises idiopathic PAH, hereditary PAH, drug-induced and associated PAH. Right heart catheterization is essential for the diagnosis of PH and should precede initiation of a targeted PAH therapy. Besides general measures and supportive therapy, four different classes of targeted drugs have been approved for the treatment of PAH. Combination therapy, either sequential or initial (up-front), is increasingly gaining recognition. Risk stratification and treatment goals have been defined to guide therapeutic decisions. However, cure is still far from reach and lung transplantation is an important treatment option for patients with end-stage disease under optimal supportive and targeted drug therapy.

U2 - 10.1055/s-0034-1392103

DO - 10.1055/s-0034-1392103

M3 - SCORING: Zeitschriftenaufsatz

C2 - 26220551

VL - 69

SP - 483-93; quiz 494-5

JO - PNEUMOLOGIE

JF - PNEUMOLOGIE

SN - 0934-8387

IS - 8

ER -